title: Metabolic disturbances after a single dose of 30 mg pamidronate for leukaemia-associated hypercalcaemia in a 11-year-old boy.
authors.forename: J
authors.initials: J
authors.lastname: De Schepper
authors.forename: S
authors.initials: S
authors.lastname: de Pont
authors.forename: J
authors.initials: J
authors.lastname: Smitz
authors.forename: D
authors.initials: D
authors.lastname: De Coster
authors.forename: R
authors.initials: R
authors.lastname: Schots
authors.forename: J
authors.initials: J
authors.lastname: Otten
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002118:Calcium / Q000378:metabolism; D002648:Child; D004164:Diphosphonates / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D006934:Hypercalcemia / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D006996:Hypocalcemia / Q000139:chemically induced*; D007938:Leukemia / Q000150:complications; D008297:Male; D000077268:Pamidronate
chemical_list: D000970:Antineoplastic Agents; D004164:Diphosphonates; D000077268:Pamidronate; D002118:Calcium